These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24680582)
1. Recommendations for scale-up of community-based misoprostol distribution programs. Robinson N; Kapungu C; Carnahan L; Geller S Int J Gynaecol Obstet; 2014 Jun; 125(3):285-8. PubMed ID: 24680582 [TBL] [Abstract][Full Text] [Related]
2. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions. Spangler SA; Gobezayehu AG; Hailemariam TG; Sibley LM J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S83-90. PubMed ID: 24588920 [TBL] [Abstract][Full Text] [Related]
3. Postpartum hemorrhage prevention in Nepal: a program assessment. Rajbhandari SP; Aryal K; Sheldon WR; Ban B; Upreti SR; Regmi K; Aryal S; Winikoff B BMC Pregnancy Childbirth; 2017 Jun; 17(1):169. PubMed ID: 28583092 [TBL] [Abstract][Full Text] [Related]
4. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia. Smith JM; Baawo SD; Subah M; Sirtor-Gbassie V; Howe CJ; Ishola G; Tehoungue BZ; Dwivedi V BMC Pregnancy Childbirth; 2014 Jun; 14():189. PubMed ID: 24894566 [TBL] [Abstract][Full Text] [Related]
5. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date. Smith JM; Gubin R; Holston MM; Fullerton J; Prata N BMC Pregnancy Childbirth; 2013 Feb; 13():44. PubMed ID: 23421792 [TBL] [Abstract][Full Text] [Related]
6. Misoprostol for preventing and treating postpartum hemorrhage in the community: a closer look at the evidence. Oladapo OT Int J Gynaecol Obstet; 2012 Nov; 119(2):105-10. PubMed ID: 22968139 [TBL] [Abstract][Full Text] [Related]
7. Effect of community-based distribution of misoprostol on facility delivery: a scoping review. Tiruneh GT; Yakob B; Ayele WM; Yigzaw M; Roro MA; Medhanyi AA; Hailu EG; Bayou YT BMC Pregnancy Childbirth; 2019 Nov; 19(1):404. PubMed ID: 31694580 [TBL] [Abstract][Full Text] [Related]
8. Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan. Smith JM; Dimiti A; Dwivedi V; Ochieng I; Dalaka M; Currie S; Luka EE; Rumunu J; Orero S; Mungia J; McKaig C Int J Gynaecol Obstet; 2014 Nov; 127(2):183-8. PubMed ID: 25051905 [TBL] [Abstract][Full Text] [Related]
9. Misoprostol for the management of postpartum bleeding: a new approach. Dabash R; Blum J; Raghavan S; Anger H; Winikoff B Int J Gynaecol Obstet; 2012 Dec; 119(3):210-2. PubMed ID: 22980431 [TBL] [Abstract][Full Text] [Related]
10. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next? Raghavan S; Abbas D; Winikoff B Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912 [TBL] [Abstract][Full Text] [Related]
11. Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: cost-effectiveness, mortality, and morbidity reduction analysis. Sutherland T; Meyer C; Bishai DM; Geller S; Miller S Int J Gynaecol Obstet; 2010 Mar; 108(3):289-94. PubMed ID: 20079493 [TBL] [Abstract][Full Text] [Related]
12. Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda. Lubinga SJ; Atukunda EC; Wasswa-Ssalongo G; Babigumira JB PLoS One; 2015; 10(11):e0142550. PubMed ID: 26560140 [TBL] [Abstract][Full Text] [Related]
13. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Tang J; Kapp N; Dragoman M; de Souza JP Int J Gynaecol Obstet; 2013 May; 121(2):186-9. PubMed ID: 23433680 [TBL] [Abstract][Full Text] [Related]
14. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana. Geller S; Carnahan L; Akosah E; Asare G; Agyemang R; Dickson R; Kapungu C; Owusu-Ansah L; Robinson N; Mensah-Homiah J BJOG; 2014 Feb; 121(3):319-25. PubMed ID: 24283350 [TBL] [Abstract][Full Text] [Related]
16. Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal. Rajbhandari S; Hodgins S; Sanghvi H; McPherson R; Pradhan YV; Baqui AH; Int J Gynaecol Obstet; 2010 Mar; 108(3):282-8. PubMed ID: 20034628 [TBL] [Abstract][Full Text] [Related]
17. Scaling Up Misoprostol to Prevent Postpartum Hemorrhage at Home Births in Mozambique: A Case Study Applying the ExpandNet/WHO Framework. Hobday K; Hulme J; Prata N; Wate PZ; Belton S; Homer C Glob Health Sci Pract; 2019 Mar; 7(1):66-86. PubMed ID: 30926738 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of different models of access to misoprostol at the community level to improve maternal health outcomes in Ethiopia, Ghana, and Nigeria. Wells E; Coeytaux F; Azasi E; Danmusa S; Geressu T; McNally T; Potts J; Otive-Igbuzor E; Tibebu S Int J Gynaecol Obstet; 2016 Jun; 133(3):261-5. PubMed ID: 27158098 [No Abstract] [Full Text] [Related]
19. Community-based availability of misoprostol: is it safe? Prata N; Mbaruku G; Grossman AA; Holston M; Hsieh K Afr J Reprod Health; 2009 Jun; 13(2):117-28. PubMed ID: 20690255 [TBL] [Abstract][Full Text] [Related]
20. Misoprostol: an essential medicine for managing postpartum hemorrhage in low-resource settings? Rushwan H Int J Gynaecol Obstet; 2011 Sep; 114(3):209-10. PubMed ID: 21745664 [No Abstract] [Full Text] [Related] [Next] [New Search]